A potentially life-saving blood test has been developed that may allow doctors to spot signs of lung cancer up to five years before the disease shows up on traditional scans.

Early results from a major trial showed how antibodies produced by the immune system in response to lung cancer could be used as a diagnostic tool.

Of around 6,000 high-risk patients screened, about one in 10 tested positive for the antibodies.

Read more


Related Articles